Edgewater Capital Partners Acquires GL CHEMTEC

ContextLogic Holdings to Acquire gChem from EagleTree Capital for $850 Million

August 5, 2026

Professional Services

ContextLogic Holdings (a long-duration business ownership platform) has entered into a definitive agreement to acquire gChem, a specialty chemicals producer based in Covington, Louisiana, from investment funds managed by EagleTree Capital and co-investors. The transaction values gChem at an enterprise value of $850 million and is expected to close by the end of 2026, subject to regulatory approvals and customary closing conditions.

Global Water Technology Acquires Brochem Industries

February 10, 2026

Industrial Services

Global Water Technology, Inc. (GWT) announced the acquisition of Brochem Industries, a private-label blender and manufacturer of water treatment chemicals serving independent and regional water treatment providers across the United States. The deal expands GWT’s Global Custom Solutions (GCS) platform and increases production capacity and operational efficiency at GWT’s Calumet City, Illinois facility.

Edgewater Capital Partners Invests in CBCC Global Research

May 27, 2025

Healthcare Services

Edgewater Capital Partners, a Cleveland-based private equity firm, has partnered with the shareholders and management of CBCC Global Research, a Bakersfield-headquartered clinical contract research organization (CRO). Edgewater's investment will support CBCC's growth by funding people, technology, and infrastructure to expand its clinical trial services across oncology, CNS, ophthalmology and other therapeutic areas.

OpenGate Capital Acquires Chemisphere Corp.

January 18, 2022

Manufacturing

OpenGate Capital, a Los Angeles-based private equity firm, has acquired Chemisphere Corp., a specialty solvent blender and chemical distributor headquartered in St. Louis, Missouri, from founder Bob Schwent. The deal complements OpenGate’s recent acquisition of Chemsolv and creates a larger chemical distribution platform spanning the Midwest to the Mid‑Atlantic, with plans for organic growth and future add-on acquisitions.

Lakelet Capital Acquires GenTech Scientific

September 30, 2020

Industrial Services

Buffalo-based private equity firm Lakelet Capital has completed an investment to support the buyout of GenTech Scientific, a refurbisher, reseller, and servicer of analytical laboratory instrumentation based in Arcade, New York. The investment provides growth capital to enhance operations, extend geographic reach, and expand solution offerings; Lakelet also installed Michael Lippa as CEO and worked with GenTech founder Clair Bragg on the transition.

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.